Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Low-dose oral minoxidil can cause serious heart complications.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

AR gene not major factor in female hair loss; different from male hair loss.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

The book concludes that treating acne scars requires a variety of methods and patience, with no single best way to classify or treat them.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

New methods like nanoparticles and microneedles show promise for better skin drug delivery, especially for hair disorders.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

PCOS is a major cause of infertility in women of childbearing age.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

The conclusion is that a combination of noninvasive treatments and lifestyle changes can improve skin health during menopause.

Ethosomes are a promising way to deliver drugs through the skin.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

SHBG may be a useful early indicator and treatment target for PCOS.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.